Get startedLog in
    Picture of Nurexone Biologic logo

    NRX — Nurexone Biologic News Story

    0.000.00%
    ca flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapMomentum Trap
    All News

    Brief: Nurexone Biologic Reports Additional Positive Preclinical Trial Outcomes With Exopten 75% Of Paralyzed Rats Show Recovery After Acute Spinal Cord Injury Study

    Picture of Nurexone Biologic logoNurexone Biologic
    20/03/2023 12:43
    March 20 (Reuters) - Nurexone Biologic Inc  NRX.V :
    * NUREXONE BIOLOGIC REPORTS ADDITIONAL POSITIVE PRECLINICAL
TRIAL
OUTCOMES WITH EXOPTEN: 75% OF PARALYZED RATS SHOW RECOVERY AFTER
ACUTE SPINAL CORD INJURY STUDY

Source text for Eikon:  ID:nGNX3F9ZYm 
Further company coverage:  NRX.V 

 ((Reuters.Briefs@thomsonreuters.com;;))

    Recent news on Nurexone Biologic

    See all news